Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following surgery. However, clinical trials have shown that this treatment doesn’t improve the chances of survival for every patient. A study published July 25th, 2024 in Cell Reports Medicine identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy.
Exercise, Education to Relieve Knee OA: Mixed Results in Modeling Study
Compared with usual care, an Australian modeling study found that a structured program of education and exercise for people with osteoarthritis (OA) of the knee
October 2, 2024